Recent advances in drug action and therapeutics: Relevance of novel concepts in G‐protein‐coupled receptor and signal transduction pharmacology
- 3 February 2004
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 57 (4), 373-387
- https://doi.org/10.1111/j.1365-2125.2003.02046.x
Abstract
During especially the past two decades many discoveries in biological sciences, and in particular at the molecular and genetic level, have greatly impacted on our knowledge and understanding of drug action and have helped to develop new drugs and therapeutic strategies. Furthermore, many exciting new drugs acting via novel pharmacological mechanisms are expected to be in clinical use in the not too distant future. In this educational review, these concepts are explained and their relevance illustrated by examples of drugs used commonly in the clinical setting, with special reference to the pharmacology of G-protein-coupled receptors. The review also addresses the basic theoretical concepts of full and partial agonism, neutral antagonism, inverse agonism and protean and ligand-selective agonism, and the relevance of these concepts in current rational drug therapy. Moreover, the mechanisms whereby receptor signalling (and eventually response to drugs) is fine-tuned, such as receptor promiscuity, agonist-directed trafficking of receptor signalling, receptor trafficking, receptor 'cross-talk' and regulators of G-protein signalling (RGSs) are discussed, from theory to proposed therapeutic implications. It is concluded that the understanding of molecular receptor and signal transduction pharmacology enables clinicians to improve their effective implementation of current and future pharmacotherapy, ultimately enhancing the quality of life of their patients.Keywords
This publication has 79 references indexed in Scilit:
- Minireview: Genomics Versus Orphan Nuclear Receptors--A Half-Time ReportMolecular Endocrinology, 2002
- International Union of Pharmacology. XXXI. Recommendations for the Nomenclature of Multimeric G Protein-Coupled ReceptorsPharmacological Reviews, 2002
- Regulators of G-Protein signalling as new central nervous system drug targetsNature Reviews Drug Discovery, 2002
- The Effect of Common Polymorphisms of the β2-Adrenergic Receptor on Agonist-Mediated Vascular DesensitizationThe New England Journal of Medicine, 2001
- Selective inactivation of guanine-nucleotide-binding regulatory protein (G-protein) α and βγ subunits by ureaBiochemical Journal, 2001
- Localization and trafficking of α2-adrenergic receptor subtypes in cells and tissuesPharmacology & Therapeutics, 1999
- Agonist-receptor efficacy II: agonist trafficking of receptor signalsTrends in Pharmacological Sciences, 1995
- Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuityTrends in Pharmacological Sciences, 1995
- The two-state model of receptor activationTrends in Pharmacological Sciences, 1995
- Chronic morphine induces tolerance and desensitization of μ-opioid receptor but not down-regulation in rabbitEuropean Journal of Pharmacology: Molecular Pharmacology, 1994